Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Pro-Dex Inc (PDEX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/14/2025: PDEX (3-star) is a STRONG-BUY. BUY since 3 days. Profits (-3.20%). Updated daily EoD!
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $56
1 Year Target Price $56
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 50.98% | Avg. Invested days 30 | Today’s Advisory Regular Buy |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 07/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 146.78M USD | Price to earnings Ratio 16.31 | 1Y Target Price 56 |
Price to earnings Ratio 16.31 | 1Y Target Price 56 | ||
Volume (30-day avg) 1 | Beta 0.18 | 52 Weeks Range 17.81 - 70.26 | Updated Date 07/14/2025 |
52 Weeks Range 17.81 - 70.26 | Updated Date 07/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2.76 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 14.61% | Operating Margin (TTM) 20.9% |
Management Effectiveness
Return on Assets (TTM) 12.73% | Return on Equity (TTM) 28.29% |
Valuation
Trailing PE 16.31 | Forward PE 18.9 | Enterprise Value 155991545 | Price to Sales(TTM) 2.29 |
Enterprise Value 155991545 | Price to Sales(TTM) 2.29 | ||
Enterprise Value to Revenue 2.43 | Enterprise Value to EBITDA 10.85 | Shares Outstanding 3261040 | Shares Floating 1815651 |
Shares Outstanding 3261040 | Shares Floating 1815651 | ||
Percent Insiders 35.95 | Percent Institutions 29.95 |
Upturn AI SWOT
Pro-Dex Inc
Company Overview
History and Background
Pro-Dex, Inc. was founded in 1978. It initially focused on contract manufacturing for various industries. Over time, it has evolved to specialize in the design, development, and manufacturing of powered surgical instruments, primarily for orthopedic surgeons.
Core Business Areas
- Powered Surgical Instruments: Designs, develops, manufactures, and markets powered surgical instruments used primarily in orthopedic surgery. These instruments include drills, saws, reamers, and other specialized tools.
- Other Contract Manufacturing: Provides contract manufacturing services for other industries, though this segment is smaller than the powered surgical instruments segment.
Leadership and Structure
Richard Van Kirk serves as President and CEO. The company has a board of directors overseeing its operations and strategic direction.
Top Products and Market Share
Key Offerings
- High-Speed Surgical Drills: High-speed surgical drills used in orthopedic procedures. Market share data for specific drill models is not publicly available, but Pro-Dex is a niche player in the broader powered surgical instrument market. Competitors include Stryker, Johnson & Johnson (DePuy Synthes), and Medtronic.
- Specialized Surgical Saws: Specialized surgical saws designed for precise bone cutting. Similar to drills, specific market share figures are not readily available. Competitors also include Stryker, Johnson & Johnson (DePuy Synthes), and Medtronic.
Market Dynamics
Industry Overview
The powered surgical instrument market is driven by factors such as an aging population, increasing demand for minimally invasive surgery, and technological advancements. The market is competitive, with several large players and smaller niche companies.
Positioning
Pro-Dex is a niche player focused on high-precision surgical instruments. Its competitive advantage lies in its ability to design and manufacture custom instruments for specific surgical applications.
Total Addressable Market (TAM)
The global powered surgical instruments market is estimated to be in the billions of dollars. Pro-Dex, as a niche player, addresses a segment of this TAM with its specialized products.
Upturn SWOT Analysis
Strengths
- Specialized expertise in powered surgical instruments
- Strong design and manufacturing capabilities
- Focus on niche markets
- Ability to develop custom instruments
Weaknesses
- Smaller size and scale compared to larger competitors
- Limited marketing and distribution resources
- Concentration of revenue in a few key products
Opportunities
- Expanding into new surgical specialties
- Developing innovative instrument designs
- Partnering with larger medical device companies
- Growth in minimally invasive surgery
Threats
- Competition from larger medical device companies
- Technological advancements that could render existing products obsolete
- Pricing pressures from hospitals and healthcare providers
- Regulatory changes in the medical device industry
Competitors and Market Share
Key Competitors
- STRY
- JNJ
- MDT
- SYK
Competitive Landscape
Pro-Dex competes with larger players in the powered surgical instrument market. It differentiates itself through its specialization in niche applications and custom instrument design. However, its smaller size limits its marketing and distribution reach compared to its larger competitors.
Major Acquisitions
Custom Machining, Inc
- Year: 2019
- Acquisition Price (USD millions): 3.5
- Strategic Rationale: Expanded manufacturing capabilities and product offerings.
Growth Trajectory and Initiatives
Historical Growth: Growth trends would need to be determined by analyzing historical financial data.
Future Projections: Future projections can be found in analyst reports or company presentations.
Recent Initiatives: Recent strategic initiatives would require real-time access to company announcements and press releases.
Summary
Pro-Dex is a niche player in the powered surgical instrument market with strengths in specialized design and manufacturing. Its smaller size and limited resources present challenges. The company's ability to capitalize on growth opportunities in minimally invasive surgery and partnerships will be critical for its future success. Competition from larger medical device companies remains a significant threat.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Website
- Industry Reports
- Market Research
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market share data is estimated. Always consult with a financial professional before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Pro-Dex Inc
Exchange NASDAQ | Headquaters Irvine, CA, United States | ||
IPO Launch date 1995-08-18 | CEO, President & Director Mr. Richard Lee Van Kirk Jr. | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 146 | Website https://www.pro-dex.com |
Full time employees 146 | Website https://www.pro-dex.com | ||
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.